Cargando…
Evaluation of Bone Mineral Density, Serum Osteocalcin, and Osteopontin Levels in Postmenopausal Women with Type 2 Diabetes Mellitus, with/without Osteoporosis
OBJECTIVE: Osteoporosis (OP) is a worldwide ailment; we aim to establish new biomarkers in diagnosis by determining the levels of serum osteocalcin and osteopontin along with bone mineral density (BMD) and lumbar T-score, in postmenopausal women with type 2 diabetes mellitus (T2DM) with or without O...
Autores principales: | Roomi, Ali B., Mahdi Salih, Abdul-Hassan, Noori, Sarmad D., Nori, Wassan, Tariq, Saba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860540/ https://www.ncbi.nlm.nih.gov/pubmed/35198139 http://dx.doi.org/10.1155/2022/1437061 |
Ejemplares similares
-
The Changes of CTX, DPD, Osteocalcin, and Bone Mineral Density During the Postmenopausal Period
por: Park, Seok Gyo, et al.
Publicado: (2018) -
Diagnostic Utility of Osteocalcin, Undercarboxylated Osteocalcin, and Alkaline Phosphatase for Osteoporosis in Premenopausal and Postmenopausal Women
por: Atalay, Sacide, et al.
Publicado: (2012) -
Association between undercarboxylated osteocalcin, bone mineral density, and metabolic parameters in postmenopausal women
por: Zanatta, Leila C. B., et al.
Publicado: (2018) -
Alkaline phosphatase is a predictor of Bone Mineral Density in postmenopausal females
por: Tariq, Sundus, et al.
Publicado: (2019) -
High Serum Osteopontin Levels Are Associated with Low Bone Mineral Density in Postmenopausal Women
por: Cho, Eun-Hee, et al.
Publicado: (2013)